BOK Financial Private Wealth, Inc.
Position in IDXX — Idexx Laboratories Inc /De
CIK 1317348
DENVER, CO
Position in IDXX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,105
+$1,279 QoQ
Shares Held
4
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,258
of 1,286 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BOK Financial Private Wealth, Inc. holds $1,903,371 across 11 Diagnostics & Research names. IDXX ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,366 | $1,687,577 | |
| 2 | WAT |
Waters Corp /De/
|
330 | $123,763 | |
| 3 | DHR |
Danaher Corp /De/
|
256 | $48,762 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
174 | $33,620 | |
| 5 | NTRA |
Natera, Inc.
|
12 | $3,257 | |
| 6 | A |
Agilent Technologies, Inc.
|
19 | $2,523 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
This page
|
4 | $2,105 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
5 | $1,133 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,105 | 4 | Shares | Sole | 2026-08-10 | |
| 2024-12-31 | $826 | 2 | Shares | Sole | 2025-02-07 | |
| 2022-03-31 | $207,882 | 380 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $289,722 | 440 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $266,795 | 429 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $224,200 | 355 | Shares | Sole | 2021-08-03 | |
| No filing history on record for this holder in this stock. | ||||||